The "Product & Company Valuation" course is designed to teach a systematic approach to producing a valuation that can be used in investment rounds, mergers/acquisitions, licensing deals, or strategic development decisions in the pharma-biotech world. This introductory course is very valuable for pharma and biotech executives who are not familiar with compound and company valuations but need a thorough understanding of the valuation concepts and techniques that are commonly applied in the pharma and biotech industries. It goes beyond the number-crunching techniques of most consultants and includes difficult to define qualitative factors, which shape the risk profile of the company in question. This course optimally balances interactive lectures with practical group work exercises that are designed to help you practice the fundamental valuation tools & techniques taught throughout the day.Valuation is an inherently subjective task, which is made even more difficult in the life science industry due to its unique challenges: high attrition rates in R&D, long investment cycle, complex technologies, IP situations, etc. Therefore, traditional valuation methods are not suitable. Of particular value in this course is the “Product Valuation and Deal Structuring” module where registrants will learn the commonly used rNPV (i.e., risk-adjusted Net Present Value) method for calculating the value of a drug in development. Subsequently, you will practice how to structure a licensing deal between companies. Registrants will use an Excel-based tool designed specifically for this module, which can be taken home for future use.Topics covered in the Product & Company Valuation course include:Introduction to valuationAssessing a company prior to valuationCompany valuation and methodsProduct valuation and methodsDeal structuringThis one-day course will be held in person on June 15, 2025, in Boston. Registration opens on January 27, 2025. …

The “Applying Game Theory to Negotiations & Decision-Making” course is designed for executives and business development professionals interested in enhancing their skills in negotiations, influencing, decision-making, and game theory. This in-person course offers a unique experience for registrants to understand how to leverage the combination of these skills, allowing for a better understanding of how one’s counterpart in the negotiations might assess potential strategic options.Registrants will learn to anticipate as well as plan strategically ahead by making use of insights from game theory, with the aim to improve the outcome of your negotiations. The learnings from game theory will be applied to real-life pharma/biotech negotiation cases. This interactive course will help participants to sharpen their business development skills by increasing the speed and quality of their decision-making and enhance negotiation skills.Topics covered in the “Applying Game Theory to Negotiations & Decision-Making” course include:The science of strategic decision-making using game theoryThree phases of negotiationsFirst and second offer strategiesInteractive group negotiationsHow to behave with emotional negotiatorsMultiple equivalent simultaneous offersNOTE: This course has a capped number of participants; people are encouraged to register early to reserve a spot.This one-day course will be held in-person on Sunday, June 15, 2025, in Boston. Registration opens on January 27, 2025.Interested in only registering for an in-person course in Boston? For course-only registration instructions, email: courseshelp@bio.orgInstructors (click photos to view bios)

The Guide to Raising Institutional Private Capital is a comprehensive course designed to teach biotech CEOs and CFOs of companies that have already raised a Series A and are preparing for a Series B or later on the most effective strategies for approaching institutional investors. The goal is to maximize the chances of successfully completing a significant private financing round.  Leveraging Locust Walk’s proven experience, participants will learn how to effectively position the company’s story, strategy, and value proposition for institutional investors. The course covers essential topics, including accurately calculating financing needs and use of proceeds, identifying appropriate institutional investors to target as a lead or syndicate member, understanding valuation methodologies for financings, dissecting the various components of a financing term sheet and their interactions, and cap table modeling.Topics covered in the Guide to Raising Institutional Private Capital course include:Portfolio & Financing Strategy and Company PositioningUse of Proceeds and BudgetingInvestor Identification and Syndicate CompositionMaterials CreationValuation Methodologies for FinancingsFinancing Term Sheet ReviewVenture Financing Math and ModelingThis one-day course will be held in person on Sunday, June 15, 2025, in Boston. Registration opens on January 27, 2025. Interested in only registering for an in-person course in Boston? For course-only registration instructions, email: courseshelp@bio.orgInstructors (click to view bios) 

Commercialization Readiness from Preclinical to 1st Launch will equip early-stage biotechnology leaders with the commercialization knowledge they need to strategically position their organizations for financing success and meeting critical commercial milestones.  The drug development process is complex and multifaceted, and understanding the commercialization considerations at each phase is vital. From preclinical to first product launch, this one-day course will help biotech executives make informed strategic choices for long-term success.   This interactive course will cover phase-specific market analysis, including a competitive landscape assessment, regulatory considerations, the Commercialization Roadmap development, FTEs and dollar spend, market access pricing and reimbursement, value proposition development, and go-to-market preparation.  Developed by Biotech Primer, BIO’s official education partner, Commercialization Readiness: From Phase 1 to 1st Launch will empower first time CEOs to navigate the commercialization journey effectively.This one-day course will be held in-person on Sunday, June 15, 2025, in Boston, Mass. Registration opens on January 27, 2025.Interested in only registering for an in-person course in Boston? For course-only registration instructions, email: courseshelp@bio.org

Formerly known as Biotechnology Entrepreneurship Boot Camp, this course is for those who are interested in becoming a biotech or MedTech entrepreneur. It covers everything from starting a company to specific market tactics. Suitable for scientists transitioning to industry, early-stage companies seeking partners or investment, and individuals with product ideas. Learn from experienced entrepreneurs and industry experts, gain critical resources, and save time with a comprehensive course.Who should take this course?Scientists and investigators who want to transition into industry.An early-stage company with technology and resources looking for additional investment or partners.People who have an idea for a product and want to know what steps they need to take to bring it to life in the marketplace.University technology transfer looking for entrepreneurs to take their spinouts.Each year, faculty from the event’s host region bring fresh insights to the program, while a core faculty returns to present material that has proven effective throughout the years. This two-day course will be held in-person, June 14--15, 2025, in Boston, Mass. Registration opens on January 27, 2025.Interested in only registering for an in-person course in Boston? For course-only registration instructions, email: courseshelp@bio.orgInstructors (click photos to view bios)